Navigation Links
Convergence Pharmaceuticals Receives Orphan-Drug Designation for Nav1.7 Blocking Pain Drug CNV1014802
Date:7/30/2013

ticals, commented: "This is a highly significant milestone for Convergence coming fast on the heels of positive interim data for '802. Trigeminal neuralgia is a highly debilitating disorder and current pain treatments come with a severe cost to quality of life. Orphan-drug designation will further smooth the path for the successful development of this novel sodium blocker and offer market exclusivity in the US if approved."

NOTES TO EDITORS

About Trigeminal Neuralgia (TN)

TN currently affects approximately 50,000 people in the USA alone. The majority of people affected are over 50 years of age; however, many cases have been reported in young adults. TN is more prevalent in women than men, and for most sufferers, the condition is progressive and worsens over time. TN is commonly misdiagnosed and to date there is no guaranteed cure for the condition. Current therapies are centred on sodium channel blockers such as carbamazepine or oxcarbazepine as first-line treatments. However, these agents, although providing relief, are often poorly tolerated, and require lengthy dose escalation, resulting in sub-optimal efficacy.

About the pain therapeutic area

The pain therapeutic area encompasses any disease where pain is a major symptom. The unmet medical need for patients in pain is enormous, with the greatest need being for a more effective therapy that is well tolerated and safe over a long period of time. Within the pain marketplace, current pain treatments are unsatisfactory; overall efficacy is poor (typically 1-2 point reductions on a 10 point scale) and satisfactory to less than 50% of patients. Whilst treatments, such as opioids and non-steroidal anti-inflammatory drugs, are available on the market, many patients obtain little or no relief from these existing analgesics and often such drugs are associated with adverse events, side effects and addiction concerns. This highlights the importance of Convergence P
'/>"/>

SOURCE Convergence Pharmaceuticals Ltd
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Convergence Pharmaceuticals Announces Start of Phase II Study for Cav2.2 Selective Blocker, CNV2197944 in Pain Associated with Post-Herpetic Neuralgia
2. Convergence Pharmaceuticals Announces Successful Interim Data from Ground-Breaking Phase II Trigeminal Neuralgia Study
3. Eighth Annual WLSA Convergence Summit Focuses on Moving from Innovation to Adoption
4. Vanda Pharmaceuticals to Announce Second Quarter 2013 Financial Results on July 31, 2013
5. Webcast Alert: Isis Pharmaceuticals Second Quarter 2013 Financial Results Conference Call
6. Insight Pharmaceuticals Considers Bananacin -- Banana-Flavored Anacin Tablets -- After Worlds Oldest Man Credits Combo As Secret To Long Life
7. Promentis Pharmaceuticals, Inc. Appoints Industry Veteran Chad Beyer, Ph.D., MBA, as President and CEO
8. Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2013 Financial Results
9. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Second Quarter 2013 Financial Results On July 31, 2013
10. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, August 1
11. Auxilium Pharmaceuticals to Announce Second Quarter 2013 Results and Conduct Conference Call on Thursday, August 1, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Md. , Aug. 29, 2014  United Therapeutics ... the U.S. District Court for the District of ... favor in the company,s case against Sandoz, Inc. regarding ... Peter Sheridan ruled that U.S. Patent No. ... and enjoined Sandoz from marketing its generic product until ...
(Date:8/29/2014)... Aug. 29, 2014  Unilife Corporation ("Unilife" or "Company") ... that it intends to release its financial results for ... 30, 2014 after market trading ends on Tuesday, September ... conference call for 4:30 p.m. U.S. EDT on Tuesday, ... a.m. AEST), to review the Company,s financial results, commercial partnerships, ...
(Date:8/29/2014)... UNION CITY, Calif. , Aug. 29, 2014 /PRNewswire/ ... products company manufacturing point-of-care blood instrumentation and consumables to ... Clint Severson , Chairman and Chief Executive Officer, ... Annual Best Ideas Conference 2014 on Tuesday, September 9, ... held at the Omni Berkshire Place Hotel in ...
Breaking Medicine Technology:District Court Decision Received In Remodulin Patent Case 2Unilife Corporation to Announce Financial Results for Fiscal Year 2014 Fourth Quarter and Year End on Tuesday, September 9, 2014 2Abaxis, Inc. to Present at CL King's 12th Annual Best Ideas Conference 2014 2
(Date:8/30/2014)... 30, 2014 Seniors Guide, the comprehensive guide ... focus on Alzheimer’s Disease, Dementia, and Memory Loss . ... public of being diagnosed with the Alzheimer’s, inspired Seniors Guide ... Be Me”. The movie, out on October 14, 2014, ... his diagnosis of the disease – which inspires a final ...
(Date:8/30/2014)... 2014 In today’s world, a good night’s ... Snoring and sleep apnea (a medical problem where the airway ... bed partners of the rest they need to face their ... snores and 20 million people in the United States alone ... and treated; and of those treated, many cannot tolerate their ...
(Date:8/30/2014)... "My niece developed a nighttime fever, and I ... fever might get worse," said an inventor from Montgomery, ... how she was doing, I developed this monitoring system." ... a child's temperature. The unit instantly alerts parents if ... medical care can be given, which is designed to ...
(Date:8/30/2014)... lead extraction (TLE) is clinically successful in more than ... Lead Extraction ConTRolled (ELECTRa) registry presented for the first ... Grazia Bongiorni, chair of the registry,s executive committee. , ... devices (CIED) implant procedures has grown in recent years. ... increased and leads are often the cause. TLE is ...
(Date:8/30/2014)... The new review published by Daily Gossip reveals ... Brimeyer, who wanted to make her guide accessible to sufferers ... now easy to find in the form of an eBook, ... author of the new method shares all her tips and ... in its review that the leaky gut syndrome can be ...
Breaking Medicine News(10 mins):Health News:Alzheimer’s Disease and Dementia Focus on Retirement Website SeniorsGuideOnline.com 2Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:Transvenous lead extraction clinically successful in 98 percent of cases 2Health News:Transvenous lead extraction clinically successful in 98 percent of cases 3Health News:Leaky Gut Cure Review Reveals Unique Method to Stop Chronic Symptoms 2
... 7 MQ Associates, Inc.,("MedQuest"), a leading national provider ... third quarter and nine months ended,September 30, 2007. ... 2007, representing,a decrease of $8.1 million, or 11.9%, from ... Net revenue was $186.5 million for the nine months,ended ...
... for retinopathy laser treatment, study finds , WEDNESDAY, Nov. ... diabetes, the drug fenofibrate reduces the need for laser ... loss and blindness among working-age adults worldwide. , Australian ... ages 50-75, who received either 200 milligrams per day ...
... 7 MED3OOO, Inc., a national healthcare,management ... Molina,Healthcare of California to provide Revenue Cycle ... communications technology, and,coding services. Molina Healthcare ... managed,healthcare companies serving patients who have traditionally ...
... BURLINGTON, Mass., Nov. 7 LeMaitre Vascular,Inc. (Nasdaq: ... medical,devices and implants for the treatment of peripheral ... Adams inaugural Cardiovascular,Conference on Tuesday, November 13, 2007, ... David B. Roberts, President of LeMaitre Vascular, ...
... Changes reflect company,s focus on growth and value ... Technologies, Inc. ("EAU",or "Company") (OTC Bulletin Board: EAUI), ... Technology" to numerous industries,including food processing, agriculture, dairy ... help the organization,better meet the needs of its ...
... cholesterol-lowering drug appears to disrupt sleep patterns of some ... Sessions 2007. , The findings are significant because sleep ... adverse health consequences, such as promoting weight gain and ... the study and an associate professor of medicine and ...
Cached Medicine News:Health News:MQ Associates, Inc. Announces Results for the Third Quarter and Nine Months Ended September 30, 2007 2Health News:MQ Associates, Inc. Announces Results for the Third Quarter and Nine Months Ended September 30, 2007 3Health News:MQ Associates, Inc. Announces Results for the Third Quarter and Nine Months Ended September 30, 2007 4Health News:MQ Associates, Inc. Announces Results for the Third Quarter and Nine Months Ended September 30, 2007 5Health News:MQ Associates, Inc. Announces Results for the Third Quarter and Nine Months Ended September 30, 2007 6Health News:MQ Associates, Inc. Announces Results for the Third Quarter and Nine Months Ended September 30, 2007 7Health News:Diabetes Drug Helps Protect Patients' Eyes 2Health News:Molina Medical Group Selects MED3OOO 2Health News:EAU Technologies Announces New Chairman of the Board and Board Leadership 2Health News:EAU Technologies Announces New Chairman of the Board and Board Leadership 3Health News:EAU Technologies Announces New Chairman of the Board and Board Leadership 4Health News:Cholesterol-lowering drug linked to sleep disruptions 2
... cannula with 30 gauge, 4.76 mm tip is ... Cannula is attached to a luer lock high ... inch long), for use with high viscosity substances. ... using visco elastic materials. Flattened, angled tip of ...
20 gauge x 25 mm cannula with 30 degree x 5 mm tip. 30 gauge cannula extends into hub 2 mm from end of hub. 10 per box....
Developed for oculoplastic procedures for corneal and scleral protection. Dimensions enable protector to rest on the sclera and not on the cornea. Easily removed with Bishop-Harmon Forceps. Individua...
The moist air humidifying chamber is designed for the infusion of humidified air during phakic fluid air exchange. Sterile single-use. 10 per box. Most popular size or model....
Medicine Products: